Investors are recovering from the holiday season, with three funding rounds exceeding $100 million this week, including Safe Superintelligence's $1 billion raise, which values the AI research lab at $5 billion. Safe Superintelligence, founded by Ilya Sutskever, focuses on developing safe AI systems amid rising regulatory concerns in California. Arsenal Biosciences secured $325 million in Series C funding for cell therapies targeting solid tumors, bringing its total funding to nearly $631 million. eGenesis raised $191 million in Series D funding to advance engineered organ development, while Circle Pharma closed a $90 million Series D round for innovative therapies, totaling nearly $208 million raised. Battery technology startup 24M Technologies collected $87 million in Series H funding, and OrsoBio raised $67 million in Series B financing for obesity treatments. Cortex Applications obtained $60 million for its software developer portal, and Oyster raised $59 million in Series D funding for its human resource platform. Laravel secured $57 million in Series A financing, and Sonoma BioTherapeutics received a $45 million milestone payment from Regeneron for autoimmune disease therapies. Sakana AI led global funding with $100 million, focusing on low-cost generative AI models.
Learn more on this news visit us at: https://greyjournal.net/